In the 1950s and 1960s, psychedelics showed promise as treatments for conditions like alcoholism, but the criminalization of psilocybin (the psychoactive substance in magic mushrooms) and LSD put research on hold.
In 2016, researchers at Johns Hopkins University tested psilocybin as a treatment for anxiety and depression in people with life-threatening cancers. They gave participants two doses of psilocybin, five weeks apart.
Researchers at the University of California San Francisco conducted a similar study using psilocybin to treat people with AIDS who had lived through the worst of the AIDS crisis.
Further studies suggest psilocybin and LSD treatments alleviate symptoms in people with treatment-resistant depression.
In 2020, a study of 24 people with Major Depressive Disorder found that “psilocybin-assisted therapy efficacious in producing large, rapid, and sustained antidepressant effects in patients with major depressive disorder.”
In a 2006 study published in the Journal of Clinical Psychiatry, nine people with Obsessive-Compulsive Disorder were given up to four single doses of psilocybin, each at least one week apart.
In a 2014 study published in the Journal of Psychopharmacology, 15 people who smoked at least 10 cigarettes a day and were unable to quit were given psilocybin three times over 15 weeks.
Shutterstock
David Gard and Josh Woolley, researchers at UCSF’s TrPR Research program, tell Inverse that psychedelics may help these conditions because they help people break patterns.
Fanatic Studio / Gary Waters/Collection Mix: Subjects/Getty Images
Shutterstock
The UCSF team plans to study psychedelics to treat mental health in conditions like Parkinson’s Disease, Bipolar, and even lower back pain. They may even be a potential treatment for Alzheimer’s Disease.